Поиск
Закладки
Озвучить текст Озвучить книгу
Изменить режим чтения
Изменить размер шрифта
Оглавление
Для озвучивания и цитирования книги перейдите в режим постраничного просмотра.
Инфекция, ассоциированная с ортопедическими имплантатами

Список литературы

  1. Брико Н.И. и др.  Профилактика инфекций области хирургического вмешательства. Методические рекомендации. / Национальная ассоциация специалистов по контролю инфекций: [сайт]. – 2022. – URL: // https://nasci.ru/?id=102733&download=1 (Дата обращения 23.10.2023).
  2. Berriós-Torres S.I. и др. Centers for disease control and prevention guideline for the prevention of surgical site infection, 2017 // JAMA Surg. 2017. Т. 152, № 8. С. 784–791.
  3. Centers for Disease and Control. CDC/NHSN Surveillance Definitions for Specific Types of Infections: Surveillance Definitions. Cdc. 2020. January. 1–36.
  4. Божкова С.А. и др. Профиль резистентности возбудителей как основа выбора эффективного антибиотика при стафилококковых инфекциях протезированных суставов. Травматология и ортопедия России. 2013; 15 (2): 115–123.
  5. Божкова С.А. и др. Неблагоприятные тенденции в этиологии ортопедической инфекции: результаты 6-летнего мониторинга структуры и резистентности ведущих возбудителей. Травматология и ортопедия России. 2018; 24 (4): 20–31.
  6. Zimmerli W. Clinical presentation and treatment of orthopaedic implant-associated infection. J. Intern. Med. 2014; 276 (2): 111–119.
  7. Божкова С.А. и др. Ортопедическая имплантат-ассоциированная инфекция: ведущие возбудители, локальная резистентность и рекомендации по антибактериальной терапии. Травматология и ортопедия России. 2013; 4 (70): 5–15.
  8. Barberán J. REVIEW Management of infections of osteoarticular prosthesis. Clin. Microbiol. Infect. 2006; 12: 93–101.
  9. Zimmerli W., Clauss M. Periprosthetic joint infection after total hip and knee arthroplasty.  Bone Jt. Infect. From Microbiol. Diagnostics Treat. 2015: 131–150.
  10. Garzoni C., Kelley W.L. Return of the Trojan horse: intracellular phenotype switching and immune evasion by Staphylococcus aureus. EMBO Mol. Med. 2011;  3 (3): 115–117.
  11. Abad L. и др. Evaluation of the ability of linezolid and tedizolid to eradicate intraosteoblastic and biofilm-embedded Staphylococcus aureus in the bone and joint infection setting. J. Antimicrob. Chemother. 2019; 74 (3): 625–632.
  12. Lora-Tamayo J. и др. High doses of daptomycin (10 mg/kg/d) plus rifampin for the treatment of staphylococcal prosthetic joint infection managed with implant retention: A comparative study. Diagn. Microbiol. Infect. Dis. 2014; 80 (1): 66–71.
  13. Fagotti L. и др. Risk Factors and Treatment Options for Failure of a Two-Stage Exchange Curr. Rev. Musculoskelet. Med. 2018; 11 (3): 420–427.
  14. Bozhkova S. и др. Failure of the first step of two-stage revision due to polymicrobial prosthetic joint infection of the hip. J. Orthop. Traumatol. 2016; 17 (4): 369–376.
  15. Bonnevialle P. и др. Early surgical site infection in adult appendicular skeleton trauma surgery: A multicenter prospective series. Orthop. Traumatol. Surg. Res. 2012; 98 (6): 684–689.
  16. Romanò C.L. и др. ICS classification system of infected osteosynthesis: Long-term results. Injury. 2018; 49 (3): 564–569.
  17. Kavanagh N. и др. Staphylococcal osteomyelitis: Disease progression, treatment challenges, and future directions. Clin. Microbiol. Rev. 2018; 31 (2).
  18. Zhang Y.H. и др. Tumor necrosis factor-α (TNF) stimulates RANKL-induced osteoclastogenesis via coupling of TNF type 1 receptor and RANK signaling pathways. J. Biol. Chem. J Biol Chem. 2001; 276 (1): 563–568.
  19. Bene N., Li X., Nandi S. Factors affecting failure of irrigation and debridement with liner exchange in total knee arthroplasty infection. Knee. 2018; 25 (5): 932–938.
  20. Tikhilov R. и др. Risk factors and a prognostic model of hip periprosthetic infection recurrence after surgical treatment using articulating and non-articulating spacers. Int. Orthop. 2016; 40 (7).
  21. Винклер Т. и др. Классификация и алгоритм диагностики и лечения перипротезной инфекции тазобедренного сустава. Травматол. Ортопед. России. 2016; 1 (1): 33–45.
  22. Ливенцов В.Н. и др. Трудноизлечимая перипротезная инфекция тазобедренного сустава: результаты санирующих операций. Травматол. Ортопед. России. 2019; 25 (4): 88–97.
  23. Shirwaiker R.A. и др. A Clinical Perspective on Musculoskeletal Infection Treatment Strategies and Challenges. J. Am. Acad. Orthop. Surg. 2015; 23 (Suppl.1): S44–S54.
  24. Birt M.C. и др. Osteomyelitis: Recent advances in pathophysiology and therapeutic strategies. J. Orthop. 2017; 14 (1): 45–52.
  25. Orthopaedic Trauma Association: Open Fracture Study Group. A new classification scheme for open fractures. J. Orthop. Trauma. 2010; 24 (8): 457–464.
  26. Rightmire E., Zurakowski D., Vrahas M. Acute infections after fracture repair: Management with hardware in place. Clin. Orthop. Relat. Res. 2008; 466 (2): 466–472.
  27. Parkkinen M. и др. Risk factors for deep infection following plate fixation of proximal tibial fractures. J. Bone Jt. Surg. (A). 2016; 98 (15): 1292–1297.
  28. Bonnevialle P. Operative treatment of early infection after internal fixation of limb fractures (exclusive of severe open fractures). Orthop. Traumatol. Surg. Res. 2017; 103 (1): S67–S73.
  29. Шубняков И.И. и др. Что изменилось в структуре ревизионного эндопротезирова- ния тазобедренного сустава в последние годы?  Травматол. Ортопед. России. 2019; 25 (4): 9–27.
  30. Материалы Второй международной согласительной конференции по лечению скелетно-мышечной инфекции /под ред. пер. с англ. ; под общ. ред. Р.М. Тихилова, С.А. Божковой, И.И. Шубнякова. СПб.: РНИИТО им. Р.Р.Вредена, 2019. 314 с.
  31. Артюх В.А. и др. Диагностика и лечение перипротезной инфекции тазобедренного сустава // Руководство по хирургии тазобедренного сустава. 2-е изд. / под ред. Тихилова Р.М., Шубнякова И.И. СПб: РНИИТО им.Р.Р.Вредена, 2015. С. 208–256.
  32. Куляба Т.А. и др. Лечение инфекционных осложнений после эндопротезирования коленного сустава // Первичное тотальное эндопротезирование коленного сустава / под ред. Куляба Т.А., Корнилова Н.Н. Киев: Основа, 2019. С. 425–486.
  33. Kurtz S.M. и др. Economic burden of periprosthetic joint infection in the United States. J. Arthroplasty. 2012; 27 (8, Suppl.): 61-65.e1.
  34. Florschutz A. V и др. Surgical site infection risk factors and risk stratification. J. Am. Acad. Orthop. Surg. 2015; 23 (Suppl.): S8–S11.
  35. Kunutsor S. и др. Systematic review of risk prediction scores for surgical site infection or periprosthetic joint infection following joint arthroplasty. Epidemiol Infect. 2017; 145: 1738–1749.
  36. Li C., Renz N., Trampuz A. Management of periprosthetic joint infection. Hip Pelvis. 2018; 30 (2): 139–146.
  37. Tsukayama D.T., Estrada R., Gustilo R.B. Infection after total hip arthroplasty: A study of the treatment of one hundred and six infections. J. Bone Jt. Surg. (A). 1996; 78 (4): 512–523.
  38. McPherson E. и др. Periprosthetic total hip infection: outcomes using a staging system. Clin Orthop Relat Res. 2002; 403: 8–15.
  39. Metsemakers W.J. и др. Fracture-related infection: A consensus on definition from an international expert group. Injury. 2018; 49 (3): 505–510.
  40. Borens O., Helmy N. Infected osteosynthesis. Chirurg. 2016; 87 (10): 822–830.
  41. Kleber C., Schaser K.D., Trampuz A. Komplikationsmanagement bei infizierter Osteosynthese: Therapiealgorithmus bei periimplantären Infektionen. Chirurg. 2015; 86 (10): 925–934.
  42. Zimmerli W., Sendi P. Orthopaedic biofilm infections. APMIS. 2017; 125 (4).
  43. Romanò C.L. и др. Bone and joint infections in adults: A comprehensive classification proposal. Eur. Orthop. Traumatol. 2011; 1 (6): 207–217.
  44. Cierny G., Mader J.T., Penninck J.J. A clinical staging system for adult osteomyelitis. Clin. Orthop. Relat. Res. 2003; 414: 7–24.
  45. Metsemakers W.J. и др. Infection after fracture fixation: Current surgical and microbiological concepts. Injury. 2018; 49 (3): 511–522.
  46. Trampuz A., Zimmerli W. Diagnosis and treatment of implantassociated septic arthritis and osteomyelitis. Curr. Infect. Dis. Rep. 2008; 10 (5): 394–403.
  47. Cuérel C. и др. Clinical and epidemiological differences between implant-associated and implant-free orthopaedic infections. Eur. J. Orthop. Surg. Traumatol. 2017; 27 (2): 229–231.
  48. Парвизи Д., Торстен Г. Материалы Второй международной согласительной конференции по скелетно-мышечной инфекции /Тихилов Р.М., Божкова С.А., Шубняков И.И. (ред.). Санкт-Петербург: РНИИТО, 2019. 314 с.
  49. Артюх В.А., Божкова С. Клинические рекомендации. Лечение параэндопротезной инфекции тазобедренного сустава. Санкт-Петербург, 2013. 40 с.
  50. Metsemakers W.J. и др. Fracture-related infection: A consensus on definition from an international expert group. Injury. 2018; 49 (3): 505–510.
  51. Parvizi J. и др. The 2018 Definition of periprosthetic hip and knee infection: an evidence-based and validated criteria. J. Arthroplasty. 2018; 33 (5): 1309-1314.
  52. Thakore R. V. и др. Surgical site infection in orthopedic trauma: A case-control study evaluating risk factors and cost. J. Clin. Orthop. Trauma. 2015; 6 (4): 220–226.
  53. Morgenstern M. и др. International survey among orthopaedic trauma surgeons: Lack of a definition of fracture-related infection. Injury. 2018; 49 (3): 491–496.
  54. Тихилов Р.М., Божкова С.А., Артюх В.А. Перипротезная инфекция в области крупных суставов конечностей. Ортопедия. Клинические рекомендации / под ред. акад. РАН С.П. Миронова. Москва, 2018. С.719–746.
  55. Osmon D.R. и др. Diagnosis and management of prosthetic joint infection: Clinical practice guidelines by the Infectious Diseases Society of America. Clin. Infect. Dis. 2013; 56 (1): 1–25.
  56. Seymour C.W. и др. Assessment of clinical criteria for sepsis for the third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016; 315 (8): 762–774.
  57. Котельников Г.П., Миронов С.П., Мирошниченко В.Ф. Травматология и ортопедия: учебник. ГОЭТАР-Мед. Москва, 2009. 400 с.
  58. Signore A. и др. Consensus document for the diagnosis of prosthetic joint infections: a joint paper by the EANM, EBJIS, and ESR (with ESCMID endorsement). Eur. J. Nucl. Med. Mol. Imaging. 2019; 46 (4): 971–988.
  59. Romano L.C. и др. The WAIOT definition of high-grade and low-grade peri-prosthetic joint infection. J. Clin. Med. 2019; 8 (650): 1–13.
  60. McNally M. и др. The EBJIS definition of periprosthetic joint infection: A practical guide for clinicians. Bone Jt. J. 2021; 103 (1): 18–25.
  61. Berbari E. и др. Inflammatory blood laboratory levels as markers of prosthetic joint infection: A systematic review and meta-analysis. J. Bone Jt Surg. (A). 2010; 92 (11): 2102–2109.
  62. Wang S. и др. Evaluating the use of serum inflammatory markers for preoperative diagnosis of infection in patients with nonunions. Biomed Res. Int. 2017; (2017): 10–14.
  63. Alijanipour P., Bakhshi H., Parvizi J. Diagnosis of periprosthetic joint infection: The threshold for serological markers. Clin. Orthop. Relat. Res. 2013; 471 (10): 3186–3195.
  64. Spangehl M.J. и др. Prospective analysis of preoperative and intraoperative investigations for the diagnosis of infection at the sites of two hundred and two revision total hip arthroplasties. J. Bone Joint Surg. (A). 1999; 81 (5): 672–683.
  65. Bosch P. и др. Limited predictive value of serum inflammatory markers for diagnosing fracture-related infections: results of a large retrospective multicenter cohort study. J. Bone Jt. Infect. 2018; 3 (3): 130–137.
  66. Omar M. и др. Synovial C-reactive protein as a marker for chronic periprosthetic infection in total hip arthroplasty. Bone Jt. J. 2015; 97-B (2): 173–176.
  67. Ettinger M. и др. Circulating biomarkers for discrimination between aseptic joint failure, low-grade infection, and high-grade septic failure. 2015.
  68. Drago L. и др. Procalcitonin, c–reactive protein, interleukin–6, and soluble intercellular adhesion molecule–1 as markers of postoperative orthopaedic joint prosthesis infections. Int. J. Immunopathol. Pharmacol. 2011; (24): 433–440.
  69. Yoon J.R., Yang S.H., Shin Y.S.. Diagnostic accuracy of interleukin–6 and procalcitonin in patients with periprosthetic joint infection: a systematic review and meta–analysis. Int. Orthop. 2018; 42: 1213–1226.
  70. Yuan K. и др. Comparison of procalcitonin and C-reactive protein for the diagnosis of periprosthetic joint infection before revision total hip arthroplasty. Surg. Infect. (Larchmt). 2015; 16 (2): 146–150.
  71. Xu H. и др. Plasma fibrin degradation product and D-dimer are of limited value for diagnosing periprosthetic joint infection. J. Arthroplasty. 2019; 34 (10): 2454–2460.
  72. Shahi A. и др. Serum D-dimer test is promising for the diagnosis of periprosthetic joint infection and timing of reimplantation. J. Bone Jt. Surg. (A). 2017; 99 (17): 1419–1427.
  73. Aggarwal V.K. и др. Swab cultures are not as effective as tissue cultures for diagnosis of periprosthetic joint infection. Clin. Orthop. Relat. Res. 2013; 471 (10): 3196–3203.
  74. Drago L. и др. The World Association against Infection in Orthopaedics and Trauma (WAIOT ) procedures for microbiological sampling and processing for periprosthetic joint infections ( PJIs ) and other. J. Clin. Med. 2019; 8 (933): 1–16.
  75. Declercq P. и др. Preoperative joint aspiration culture results and causative pathogens in total hip and knee prosthesis infections: mind the gap. Acta Clin. Belg. 2020; 75 (4): 284–292.
  76. Cipriano C.A. и др. Serum and synovial fluid analysis for diagnosing chronic periprosthetic infection in patients with inflammatory arthritis. J Bone Jt. Surg. Am. 2012; 94 (7): 594–600.
  77. Carli A.V. и др Diagnostic accuracy of serum, synovial, and tissue testing for chronic periprosthetic joint infection after hip and knee replacements: a systematic review. J. Bone Joint Surg Amer. 2019; 101 (7): 635-649.
  78. Schinsky, M.F. и др. Perioperative testing for joint infection in patients undergoing revision total hip arthroplasty. J Bone Jt. Surg Am. 2008; 90 (9): 1869–1875.
  79. Zmistowsky B. и др. Periprosthetic joint infection diagnosis: a complete understanding of white blood cell count and differential. J. Arthroplast. 2012; 27 (9): 1589–1593.
  80. Vasoo S. и др. Evaluation of the film array blood culture ID panel on biofilms dislodged from explanted arthroplasties for prosthetic joint infection diagnosis. J. Clin. Microbiol. 2015; 53 (8): 2790–2792.
  81. Tande A.J., Patel R. Prosthetic joint infection. Clin. Microbiol. Rev. 2014; 27 (2): 302–345.
  82. Atkins B.L. и др. Prospective evaluation of criteria for microbiological diagnosis of prosthetic-joint infection at revision arthroplasty. J. Clin. Microbiol. 1998; 36 (10): 2932–2939.
  83. Cazanave C. и др. Rapid molecular microbiologic diagnosis of prosthetic joint infection. J. Clin. Microbiol. 2013; 51 (7): 2280–2287.
  84. Esteban J. и др. Evaluation of quantitative analysis of cultures from sonicated retrieved orthopedic implants in diagnosis of orthopedic infection. J. Clin. Microbiol. 2008; 46 (2): 488–492.
  85. Frangiamore S. и др. Alfa-defensin accuracy to diagnose periprosthetic joint infection - best available test? J. Arthroplast. 2016; 31 (2): 456–460.
  86. Janz V. и др. Improved identification of polymicrobial infection in total knee arthroplasty through sonicate fluid cultures. Arch. Orthop. Trauma Surg. 2015; 135 (10): 1453–1457.
  87. Minassian A. и др. Use of an automated blood culture system (BD BACTEC) for the diagnosis of prosthetic joint infections: easy and fast. BMC Infect Dis. 2014; 14: 233.
  88. Tomas X. и др. Accuracy of CT-guided joint aspiration in patients with suspected infection status post-total hip arthroplasty. Skelet Radiol. 2011; 40 (1): 57–64.
  89. Hindle P., Davidson E., Biant L.C. Septic arthritis of the knee: the use and effect of antibiotics prior to diagnostic aspiration. Ann. R. Coll. Surg. Engl. 2012; 94 (5): 351–355.
  90. Hoell S. и др. Interleukin-6 in two-stage revision arthroplasty: what is the threshold value to exclude persistent infection before re-implantation? Bone Jt. J. 2015; 97-B (1): 71–75.
  91. Trampuz A. и др. Sonication of removed hip and knee prostheses for diagnosis of infection. N. Engl. J. Med. 2007; 357 (7): 654–663.
  92. Trampuz A. и др. Sonication of explanted prosthetic components in bags for diagnosis of prosthetic joint infection is associated with risk of contamination. J. Clin. Microbiol. 2006; 44 (2): 628–631.
  93. Suda A.J. и др. Diagnosis of periprosthetic joint infection using alpha-defensin test or multiplex-PCR: ideal diagnostic test still not found. Int. Orthop. 2017; 41 (7): 1307–1313.
  94. Morgenstern C. и др. Synovial fluid multiplex PCR is superior to culture for detection of low-virulent pathogens causing periprosthetic joint infection. Diagn. Microbiol. Infect. Dis. 2018; 90 (2): 115–119.
  95. Bingham J. и др. The alpha defensin-1 biomarker assay can be used to evaluate the potentially infected total joint arthroplasty. Clin. Orthop. Relat. Res. 2014; 472 (12): 4006–4009.
  96. Lenski M., Scherer M.A. Synovial IL-6 AS inflammatory marker in periprosthetic joint infections. J. Arthroplasty. 2014; 29 (6): 1105–1109.
  97. Deirmengian C. и др. Combined measurement of synovial fluid a-defensin and C-reactive protein levels: Highly accurate for diagnosing periprosthetic joint infection. J. Bone Jt. Surg. (A). 2014; 96 (17): 1439–1445.
  98. Deirmengian C. и др. Diagnosing periprosthetic joint infection: has the era of the biomarker arrived? Clin. Orthop. Relat. Res. 2014; 472 (11): 3254–3262.
  99. Achermann Y. и др. Improved diagnosis of periprosthetic joint infection by multiplex PCR of sonication fluid from removed implants. J. Clin. Microbiol. 2010; 48 (4): 1208–1214.
  100. Wetters N.G. и др. Leukocyte esterase reagent strips for the rapid diagnosis of periprosthetic joint infection. J. Arthroplasty. 2012; 27 (8, Suppl.): 8–11.
  101. Goswami K., Parvizi J., Maxwell Courtney P. Current recommendations for the diagnosis of acute and chronic PJI for hip and knee—cell counts, alpha-defensin, leukocyte esterase, next-generation sequencing. Curr. Rev. Musculoskelet. Med. 2018; 11 (3): 428–438.
  102. Lee Y.S. и др. Synovial fluid biomarkers for the diagnosis of periprosthetic joint infection : A systematic review and meta-analysis. J. Bone Jt. Surg. (A).  2017; 99 (24).
  103. Carli A. V. и др. Diagnostic accuracy of serum, synovial, and tissue testing for chronic periprosthetic joint infection after hip and knee replacements: a systematic review. J. Bone Jt. Surg. (A). 2019; 101 (7).
  104. Frangiamore S.J. и др. Synovial fluid interleukin-6 as a predictor of periprosthetic shoulder infection. J. Bone Jt. Surg. (A). 2015; 97 (1): 63–70.
  105. Карбышева С.Б. и др. D-лактат – маркер бактериального воспаления нативных и протезированных суставов. Травматол. Ортопед. России. 2017; 23 (2): 6–14.
  106. Karbysheva S. и др. New methods in the diagnosis of prosthetic joint infection. Traumatol. Orthop. Russ. 2019; 25 (4): 56–63.
  107. De Vecchi E. и др. Alpha defensin, leukocyte esterase, C-reactive protein, and leukocyte count in synovial fluid for pre-operative diagnosis of periprosthetic infection. Int. J. Immunopathol. Pharmacol. 2018; 32: 2058738418806072.
  108. Parvizi J. и др. Mark B. Coventry award. Clin. Orthop. Relat. Res. 2012; 470 (1): 54–60.
  109. Weigelt L., Plate A., Stadler L. et al. Alpha-defensin lateral flow test does not appear to be useful in predicting shoulder periprosthetic joint infections. Int Orthop. 2020; 44(6): 1023-1029.
  110. Onsea J. и др. Accuracy of tissue and sonication fluid sampling for the diagnosis of fracture-related infection: a systematic review and critical appraisal. J. Bone Jt. Infect. 2018; 3 (4): 173–181.
  111. Божкова С.А. и др. Профилактика, диагностика и лечение тромбоэмболических осложнений в травматологии и ортопедии: методические рекомендации. Травматол. Ортопед. России. 2022; 28 (3): 136-166.
  112. Govaert G.A.M. и др. Diagnosing fracture-related infection: current concepts and recommendations. J. Orthop. Trauma. 2020; 34 (1): 8–17.
  113. Burns T.C. и др. Microbiology and injury characteristics in severe open tibia fractures from combat. J. Trauma Acute Care Surg. 2012; 72 (4): 1062–1067.
  114. Li C. и др. Twenty common errors in the diagnosis and treatment of periprosthetic joint infection. Int. Orthop. 2020; 44 (1): 3–14.
  115. Zimmerli W. Clinical presentation and treatment of orthopaedic implant-associated infection. J. Intern. Med. 2014; 276 (2): 111–119.
  116. Boettner F. и др. The rule of histology in the diagnosis of periprosthetic infection: specific granulocyte counting methods and new immunohistologic staining techniques may increase the diagnostic value. Open Orthop. J. 2017; 10 (1): 457–465.
  117. Morgenstern M. и др. The value of quantitative histology in the diagnosis of fracture-related infection. Bone Jt. J. 2018; 100B (7): 966–972.
  118. Omar M. и др. Higher sensitivity of swab polymerase chain reaction compared with tissue cultures for diagnosing periprosthetic joint infection. J. Orthop. Surg. (Hong Kong). 2018; 26 (1): 2309499018765296.
  119. Bémer P. и др. How many samples and how many culture media to diagnose a prosthetic joint infection: A clinical and microbiological prospective multicenter study. J. Clin. Microbiol. 2016; 54 (2): 385–391.
  120. Peel T.N. и др. Optimal periprosthetic tissue specimen number for diagnosis of prosthetic joint infection. J. Clin. Microbiol. 2017; 55 (1).
  121. Janz V. и др. Reduced culture time and improved isolation rate through culture of sonicate fluid in blood culture bottles. Technol. Heal. Care. 2017; 25 (4): 635–640.
  122. Rothenberg A.C. и др. Sonication of arthroplasty implants improves accuracy of periprosthetic joint infection cultures. Clin. Orthop. Relat. Res. 2017; 475 (7): 1827–1836.
  123. Кренн Ф. и др. Новый алгоритм гистопатологической диагностики перипротезной инфекции с применением шкалы cd15 focus score и компьютерной программы cd15 Quantifier. Травматол. Ортопед. России. 2015; 3 (3): 76–85.
  124. Куковенко Г.А. и др. Важность выполнения алгоритма диагностики поздней глубокой перипротезной инфекции тазобедренного сустава. Травматол. Ортопед. России. 2019; 25 (4): 75–87.
  125. Krenn V. и др. Revised histopathological consensus classification of joint implant related pathology. Pathol Res Pr. 2014; 210 (12): 779–786.
  126. Math K.R. и др. Imaging of total knee arthroplasty. Semin. Musculoskelet. Radiol. 2006; 10 (1): 47–63.
  127. Van Holsbeeck M.T. и др. Detection of infection in loosened hip prostheses: efficacy of sonography. Am. J. Roentgenol. 1994; 163 (2): 381–384.
  128. Eisler T. и др. Ultrasound for diagnosis of infection in revision total hip arthroplasty. J. Arthroplasty. 2001; 16 (8): 1010–1017.
  129. Battaglia M. и др. Validity of preoperative ultrasound-guided aspiration in the revision of hip prosthesis. Ultrasound Med. Biol. 2011; 37 (12): 1977–1983.
  130. Sconfienza L.M. и др. Diagnosis of peripheral bone and prosthetic joint infections: overview on the consensus documents by the EANM, EBJIS, and ESR (with ESCMID endorsement). Eur. Radiol. 2019; 29 (12): 6425–6438.
  131. Patzakis M.J., Zalavras C.G. Chronic posttraumatic osteomyelitis and infected nonunion of the tibia: current management concepts. J. Am. Acad. Orthop. Surg. 2005; 13 (6): 417–427.
  132. Gross T. и др. Current concepts in posttraumatic osteomyelitis: a diagnostic challenge with new imaging options. J. Trauma. 2002; 52 (6): 1210–1219.
  133. Perlepe V. и др. Semi-quantitative CT assessment of fracture healing: How many and which CT reformats should be analyzed? Eur. J. Radiol. 2019; 118: 181–186.
  134. Ledermann H. и др. Pitfalls and limitations of magnetic resonance imaging in chronic posttraumatic osteomyelitis. Eur. Radiol. 2000; 10 (11): 1815–1823.
  135. Love C., Palestro C.J. Nuclear medicine imaging of bone infections. Clin. Radiol. 2016; 71 (7): 632–646.
  136. Glaudemans A.W.J.M. и др. Diagnosing fracture-related infections: can we optimize our nuclear imaging techniques? Eur. J. Nucl. Med. Mol. Imaging. 2019; 46 (8): 1583–1587.
  137. Gemmel F. и др. Prosthetic joint infections: Radionuclide state-of-the-art imaging. Eur. J. Nucl. Med. Mol. Imaging. 2012; 39 (5): 892–909.
  138. Reinartz P. FDG-PET in patients with painful hip and knee arthroplasty: Technical breakthrough or just more of the same Q. J. Nucl. Med. Mol. Imaging. 2009; 53 (1): 41–50.
  139. Jamar F. и др. EANM/SNMMI guideline for 18F-FDG use in inflammation and infection J. Nucl. Med. 2013; 54 (4): 647–658.
  140. van der Bruggen W. и др. PET and SPECT in osteomyelitis and prosthetic bone and joint infections: a systematic review. Semin. Nucl. Med. 2010; 40 (1): 3–15.
  141. Valenziano C.P. и др. Efficacy of primary wound cultures in long bone open extremity fractures: Are they of any value? Arch. Orthop. Trauma Surg. 2002; 122 (5): 259–261.
  142. Xu C. и др. Reevaluating current cutoffs for acute periprosthetic joint infection: current thresholds are insensitive. J. Arthroplasty. 2019; 34 (11): 2744–2748.
  143. Yi P.H. et al. Is potential malnutrition associated with septic failure and acute infection after revision total joint arthroplasty? Clin Orthop Relat Res. 2015; 473: 175–182.
  144. Jaberi F.M. et al. Procrastination of wound drainage and malnutrition affect the outcome of joint arthroplasty. Clin Orthop Relat Res. 2008; 466 (6): 1368-71.
  145. Chou R. и др. Management of postoperative pain: A clinical practice guideline from the American pain society, the American society of regional anesthesia and pain medicine, and the American society of anesthesiologists’ committee on regional anesthesia, executive committee, and administrative council. J. Pain. 2016; 17 (2): 131–157.
  146. Lora-Tamayo J. и др. Short- versus long-duration levofloxacin plus rifampicin for acute staphylococcal prosthetic joint infection managed with implant retention: a randomised clinical trial. Int. J. Antimicrob. Agents. 2016; 48 (3): 310–316.
  147. Puhto A.P., Puhto T., Syrjala H. Short-course antibiotics for prosthetic joint infections treated with prosthesis retention. Clin. Microbiol. Infect. 2012; 18 (11): 1143–1148.
  148. Chaussade H. и др. Antibiotic therapy duration for prosthetic joint infections treated by Debridement and Implant Retention (DAIR): Similar long-term remission for 6 weeks as compared to 12 weeks. Int. J. Infect. Dis. 2017; 63: 37–42.
  149. Legout L. и др. Tolerability of prolonged linezolid therapy in bone and joint infection: Protective effect of rifampicin on the occurrence of anaemia? J. Antimicrob. Chemother. 2010; 65 (10): 2224–2230.
  150. Chang Y.J. et al. Daptomycin treatment in patients with resistant staphylococcal periprosthetic joint infection. BMC Infect Dis. 2017; 17: 736. 
  151. Lora-Tamayo J. и др. High doses of daptomycin (10 mg/kg/d) plus rifampin for the treatment of staphylococcal prosthetic joint infection managed with implant retention: A comparative study. Diagn. Microbiol. Infect. Dis. 2014; 80 (1): 66–71.
  152. Thabit A.K. и др. Antibiotic penetration into bone and joints: An updated review. Int. J. Infect. Dis. 2019; 81.
  153. Lesens O. и др. Should we expand the indications for the DAIR (debridement, antibiotic therapy, and implant retention) procedure for Staphylococcus aureus prosthetic joint infections? A multicenter retrospective study. Eur. J. Clin. Microbiol. Infect. Dis. 2018; 37 (10): 1949–1956.
  154. Scheper H. и др. Outcome of debridement, antibiotics, and implant retention for staphylococcal hip and knee prosthetic joint infections, focused on rifampicin use: a systematic review and meta-analysis. Open forum Infect. Dis. 2021; 8 (7): ofab298.
  155. Becker A. и др. Duration of rifampin therapy is a key determinant of improved outcomes in early-onset acute prosthetic joint infection due to Staphylococcus treated with a debridement, antibiotics and implant retention (DAIR): a retrospective multicenter study in France. J. bone Jt. Infect. 2020; 5 (1): 28–34.
  156. Scarborough M. et al. Oral versus intravenous antibiotics for bone and joint infections: the OVIVA non-inferiority RCT. Health Technol Assess. 2019; 23 (38): 1-92.
  157. Perez-Jorge C. и др. Drug treatments for prosthetic joint infections in the era of multidrug resistance. Expert Opin. Pharmacother. 2016; 17 (9): 1233–1246.
  158. Depypere M. и др. Recommendations for Systemic antimicrobial therapy in fracture-related infection: a consensus from an International Expert Group. J. Orthop. Trauma. 2020; 34 (1): 30–41.
  159. Zimmerli W., Sendi P. 105 - Orthopedic implant– associated infections //Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. 9th Ed. Elsevier Inc., 2020: 1430-1442.
  160. Davis J.S. и др. Proposed empiric antibiotic therapy for prosthetic joint infections: an analysis of the Prosthetic Joint Infection in Australia and New Zealand, Observational (PIANO) cohort. Intern. Med. J. 2022; 52 (2): 322–325.
  161. Mao An M. и др. Linezolid versus vancomycin for meticillin-resistant Staphylococcus aureus infection: a meta-analysis of randomised controlled trials. Int. J. Antimicrob. Agents. 2013; 41: 426–433.
  162. Theil C. et al. Clinical use of linezolid in periprosthetic joint infections - a systematic review. J Bone Jt Infect. 2020; 6 (1): 7-16.
  163. Perez-Jorge C. и др. Drug treatments for prosthetic joint infections in the era of multidrug resistance. Expert Opinion Pharmacother. 2016; 17 (9): 1233–1246.
  164. Wouthuyzen-Bakker M. и др. Moxifloxacin plus rifampin as an alternative for levofloxacin plus rifampin in the treatment of a prosthetic joint infection with Staphylococcus aureus. Int. J. Antimicrob. Agents. 2018; 51 (1): 38–42.
  165. Papadopoulos A. и др. Multidrug-resistant and extensively drug-resistant Gram-negative prosthetic joint infections: Role of surgery and impact of colistin administration. Int. J. Antimicrob. Agents. 2019; 53 (3): 294–301.
  166. Kalbian I.L. и др. Treatment outcomes and attrition in gram-negative periprosthetic joint infection. J. Arthroplasty. 2020; 35 (3): 849–854.
  167. Bozhkova S. и др. Failure of the first step of two-stage revision due to polymicrobial prosthetic joint infection of the hip. J. Orthop. Traumatol. 2016; 17 (4).
  168. Boyle K.K. и др. General assembly, treatment, antimicrobials: proceedings of International Consensus on Orthopedic Infections. J. Arthroplasty. 2019; 34 (2): S225–S237.
  169. Backes M. и др. Effect of antibiotic prophylaxis on surgical site infections following removal of orthopedic implants used for treatment of foot, ankle, and lower leg fractures a randomized clinical trial. JAMA. 2017; 318 (24): 2438–2445.
  170. Pradier M. и др. Suppressive antibiotic therapy with oral tetracyclines for prosthetic joint infections: a retrospective study of 78 patients. Infection. 2018; 46 (1): 39–47.
  171. Pradier M. и др. Suppressive antibiotic therapy with oral doxycycline for Staphylococcus aureus prosthetic joint infection: a retrospective study of 39 patients. Int. J. Antimicrob. Agents. 2017; 50 (3): 447–452.
  172. Siqueira M.B.P. и др. Chronic suppression of periprosthetic joint infections with oral antibiotics increases infection-free survivorship. J. Bone Jt. Surg. (A). 2014; 97 (15): 1220–1232.
  173. Troendlin F. и др. Persistent fistula for treatment of a failed periprosthetic joint infection: relic from the past or a viable salvage procedure? J. Arthroplasty. 2020; 35 (2): 544–549.
  174. Rao N. и др. Long term suppression of infection in total joint arthroplasty. Clin. Orthop. 2003; 414: 55–60.
  175. Vees T., Hofmann G.O. Early periprosthetic infection: dilution, jet dilution or local antibiotics. Which way to go? A meta-analysis on 575 patients. GMS Interdiscip. Plast. Reconstr. Surg. DGPW. 2020; 9: Doc03.
  176. Божкова С.А., Новокшонова А.А., Конев В.А. Современные возможности локальной антибиотикотерапии перипротезной инфекции и остеомиелита (Обзор литературы). Травматол. Ортопед. России. 2015; 77 (3): 92–107.
  177. Argenson J.N. и др. Hip and knee section, treatment, debridement and retention of implant: Proceedings of International Consensus on Orthopedic Infections. J. Arthroplasty. 2019; 34 (2): S399–S419.
  178. Romanò C.L. и др. Local antibacterial implant protection in orthopedics and trauma: what’s new? Travmatol. Ortop. Ross. 2019; 25 (4): 64–74.
  179. Proceedings of the International Consensus Meeting on Periprosthetic Joint Infection. Foreword. J Orthop Res. 2014. S2-S3.
  180. Acute Management of Peri-prosthetic Joint Infection. 2023 https://www.boa.ac.uk/static/1d7d2f54-34b7-4c96-8a0eb80bae3e3a07/e277bd57-a872-4f3d-bb61d6fae28edc51/BOAST-Acute-Management-of-PJI.pdf (дата обращения 21.02.2024).
  181. Сепсис: классификация, клинико-диагностическая концепция и лечение. 4-е изд. Под ред. Акад. РАН Б.Р. Гельфанда. М., 2017: С.66–70,
  182. Ghnaimat M. и др. Is DAIR still an effective way to eradicate acute prosthetic joint infections? our experience in the Jordanian Royal Medical Services. Med. Arch. 2021; 75 (6): 451–455.
  183. Nurmohamed F.R.H.A. и др. One-year infection control rates of a DAIR (debridement, antibiotics and implant retention) procedure after primary and prosthetic-joint-infection-related revision arthroplasty - a retrospective cohort study. J. Bone Jt. Infect. 2021; 6 (4): 91–97.
  184. van der Ende B. и др. Timing of debridement, antibiotics, and implant retention (DAIR) for early post-surgical hip and knee prosthetic joint infection (PJI) does not affect 1-year re-revision rates: data from the Dutch Arthroplasty Register. J. Bone Jt. Infect. 2021; 6 (8): 329–336.
  185. Bryan A.J. и др. Irrigation and debridement with component retention for acute infection after hip arthroplasty : Improved results with contemporary management. J. Bone Jt. Surg. (A). 2017;  99 (23): 2011–2018.
  186. Son W.S. и др. Efficacy of open debridement and polyethylene exchange in strictly selected patients with infection after total knee arthroplasty. Knee Surg. Relat. Res. 2017; 29 (3): 172–179.
  187. Tsang S.T.J. и др. Outcomes following debridement, antibiotics and implant retention in the management of periprosthetic infections of the hip: A review of cohort studies. Bone Jt J. (Br). 2017; 99B (11): 1458–1466.
  188. Triantafyllopoulos G.K. и др. Implant retention after acute and hematogenous periprosthetic hip and knee infections: Whom, when and how? World J. Orthop. 2016; 7 (9): 546–552.
  189. Buller L.T. и др. The preoperative prediction of success following irrigation and debridement with polyethylene exchange for hip and knee prosthetic joint infections. J. Arthroplasty. 2012; 27 (6).
  190. Volpin A. и др. Aggressive early debridement in treatment of acute periprosthetic joint infections after hip and knee replacements. Open Orthop. J. 2016; 10 (1): 669–678.
  191. Swenson R.D. и др. Preoperative anemia is associated with failure of open debridement polyethylene exchange in acute and acute hematogenous prosthetic joint infection. J. Arthroplasty. 2018; 33 (6): 1855–1860.
  192. Triantafyllopoulos G.K. и др. Implant retention after acute and hematogenous periprosthetic hip and knee infections: Whom, when and how? World J. Orthop. 2016; 7 (9): 546–552.
  193. Rodríguez-Pardo D. и др. Gram-negative prosthetic joint infection: Outcome of a debridement, antibiotics and implant retention approach. A large multicentre study. Clin. Microbiol. Infect. 2014; 20 (11): O911–O919.
  194. Vilchez F. и др. Outcome and predictors of treatment failure in early post-surgical prosthetic joint infections due to Staphylococcus aureus treated with debridement. Clin. Microbiol. Infect. 2011; 17 (3): 439–444.
  195. Konigsberg B.S. и др. Acute hematogenous infection following total hip and knee arthroplasty. J. Arthroplasty. 2014; 29 (3): 469–472.
  196. Sendi P. и др. Clinical comparison between exogenous and haematogenous periprosthetic joint infections caused by Staphylococcus aureus. Clin. Microbiol. Infect. 2011; 17 (7): 1098–1100.
  197. Goud A.L., Harlianto N.I., Ezzafzafi S. et al. Reinfection rates after one- and two-stage revision surgery for hip and knee arthroplasty: a systematic review and meta-analysis. Arch Orthop Trauma Surg. 2023; 143(2): 829-838.
  198. Kunutsor S.K. и др. Re-infection outcomes following one- and two-stage surgical revision of infected knee prosthesis: A systematic review and meta-analysis. PLoS One. 2016; 11 (3).
  199. Van Den Kieboom J. и др. One-stage revision is as effective as twostage revision for chronic culture-negative periprosthetic joint infection after total hip and knee arthroplasty a retrospective cohort study. Bone Jt. J. (Br). 2021; 103-B (3): 515–521.
  200. Winkler H. и др. One stage uncemented revision of infected total hip replacement using cancellous allograft bone impregnated with antibiotics. J. Bone Jt. Surg. (Br.). 2008; 90 (12): 1580–1584.
  201. Whiteside L.A., Roy M.E. One-stage revision with catheter infusion of intraarticular antibiotics successfully treats infected THA. Clin. Orthop. Relat. Res. 2017; 475 (2): 419–429.
  202. Gehrke T., Zahar A., Kendoff D. One-stage exchange: it all began here. Bone Joint J. 2013; 95-B (11): 77–83.
  203. Hip & Knee – ICM Philly [Электронный ресурс]. URL: https://icmphilly.com/hip-knee/ (дата обращения: 22.05.2022).
  204. Zahar A. и др. Ten-year results following one-stage septic hip exchange in the management of periprosthetic joint infection. J. Arthroplasty. 2019; 34 (6): 1221–1226.
  205. Bori G. и др. Preliminary results after changing from two-stage to one-stage revision arthroplasty protocol using cementless arthroplasty for chronic infected hip replacements. J. Arthroplasty. 2018; 33 (2): 527–532.
  206. Jenny J.Y. и др. Routine one-stage exchange for chronic infection after total hip replacement. Int. Orthop. 2014; 38 (12): 2477–2481.
  207. Jenny J.Y. и др. High infection control rate and function after routine one-stage exchange for chronically infected TKA knee. Clin. Orthop. Relat. Res. 2013; 471 (1): 238–243.
  208. Wolf M. и др. Prosthetic joint infection following total hip replacement: Results of one-stage versus two-stage exchange. Int. Orthop. 2014; 38 (7): 1363–1368.
  209. Zahar A., Gehrke T.A. One-stage revision for infected total hip arthroplasty. Orthop. Clin. N. Am. 2016; 47 (1): 11–18.
  210. Klouche S. и др. Infected total hip arthroplasty revision: One- or two-stage procedure? Orthop. Traumatol. Surg. Res. 2012; 98 (2): 144–150.
  211. Akgün D. и др. Outcome of hip and knee periprosthetic joint infections caused by pathogens resistant to biofilm-active antibiotics: results from a prospective cohort study. Arch. Orthop. Trauma Surg. 2018; 138 (5): 635–642.
  212. Kunutsor S.K. и др. Clinical effectiveness of treatment strategies for prosthetic joint infection following total ankle replacement: a systematic review and meta-analysis. J. Foot Ankle Surg. 2020; 59 (2): 367–372.
  213. Kunutsor S.K. и др. Re-infection outcomes following one- and two-stage surgical revision of infected knee prosthesis: A systematic review and meta-analysis. PLoS ONE. 2016; 11 (3).
  214. Lichstein P. и др. Treatment of periprosthetic knee infection with a two-stage protocol using static spacers. Clin. Orthop. Relat. Res. 2016; 474 (1): 120–125.
  215. Park S.J. и др. Comparison of static and mobile antibiotic-impregnated cement spacers for the treatment of infected total knee arthroplasty. Int. Orthop. 2010; 34 (8): 1181–1186.
  216. Chiang E.R. и др. Comparison of articulating and static spacers regarding infection with resistant organisms in total knee arthroplasty. Acta Orthop. 2011; 82 (4): 460–464.
  217. Van Thiel G.S. и др. Intraoperative molds to create an articulating spacer for the infected knee arthroplasty. Clin. Orthop. Relat. Res. 2011; 469 (4): 994–1001.
  218. Choi H.R., Malchau H. Are prosthetic spacers safe to use in 2-stage treatment for infected total knee arthroplasty? J. Arthroplasty. 2012; 27 (8).
  219. Hofmann A.A. и др. Ten-year experience using an articulating antibiotic cement hip spacer for the treatment of chronically infected total hip. J. Arthroplasty. 2005; 20 (7): 874–879.
  220. Citak M. и др. Are preformed articulating spacers superior to surgeon-made articulating spacers in the treatment of PJI in THA? A literature review. Open Orthop. J. 2015; 9 (1): 255–261.
  221. Cabo J. и др. Clinical outcome and microbiological findings using antibiotic-loaded spacers in two-stage revision of prosthetic joint infections. J. Infect. 2011; 63 (1): 23–31.
  222. Sorlí L. и др. The relationship between microbiology results in the second of a two-stage exchange procedure using cement spacers and the outcome after revision total joint replacement for infection: The use of sonication to aid bacteriological analysis. J. Bone Jt. Surg. (B). 2012; 94 B (2): 249–253.
  223. Nelson C.L. и др. Sonication of antibiotic spacers predicts failure during two-stage revision for prosthetic knee and hip infections. Clin. Orthop. Relat. Res. 2014; 472 (7): 2208–2214.
  224. El-Husseiny M., Haddad F.S. The role of highly selective implant retention in the infected hip arthroplasty. Clin. Orthop. Relat. Res. 2016; 474 (10): 2157–2163.
  225. Fukui K. и др. Should well-fixed uncemented femoral components be revised in infected hip arthroplasty? Report of five trial cases. J. Orthop. 2016; 13 (4): 437–442.
  226. Miner T.M. и др. The extended trochanteric osteotomy in revision hip arthroplasty: A critical review of 166 cases at mean 3-year, 9-month follow-up. J. Arthroplasty. 2001; 16 (8, Suppl. 1): 188–194.
  227. Struhl S. и др. Infected uncemented hip arthroplasty. Preserving the femoral stem with a two-stage revision procedure. Orthop Rev. 1989; 18 (6): 707–712.
  228. Ji B. и др. Retention of the well-fixed implant in the single-stage exchange for chronic infected total hip arthroplasty: an average of five years of follow-up. Int. Orthop. 2017; 41 (5): 901–909.
  229. Rahman W.A., Kazi H.A., Gollish J.D. Results of single stage exchange arthroplasty with retention of well fixed cement-less femoral component in management of infected total hip arthroplasty. World J. Orthop. 2017; 8 (3): 264–270.
  230. Triantafyllopoulos G.K. и др. Periprosthetic infection recurrence after 2-stage exchange arthroplasty: failure or fate? J. Arthroplasty. 2017; 32 (2): 526–531.
  231. Babis G.C. и др. Two-stage revision protocol in multidrug resistant periprosthetic infection following total hip arthroplasty using a long interval between stages. J. Arthroplasty. 2015; 30 (9): 1602–1606.
  232. Лю Б. и др. Эффективность первого этапа двухэтапной ревизии при параэндопротезной инфекции тазобедренного сустава. Травматол. Ортопед. России. 2014; 73 (3): 5–14.
  233. Edelstein A.I. и др. Nephrotoxicity after the treatment of periprosthetic joint infection with antibiotic-loaded cement spacers. J. Arthroplasty. 2018; 33 (7): 2225–2229.
  234. Geller J.A. и др. Acute kidney injury after first-stage joint revision for infection: risk factors and the impact of antibiotic dosing. J. Arthroplasty. 2017; 32 (10): 3120–3125.
  235. James A., Larson T. Acute renal failure after high-dose antibiotic bone cement: case report and review of the literature. Ren. Fail. 2015; 37 (6): 1061–1066.
  236. Winkler T. и др. Outcome of short versus long interval in two-stage exchange for periprosthetic joint infection: a prospective cohort study. Arch. Orthop. Trauma Surg. 2019; 139 (3): 295–303.
  237. Karczewski D. и др. A standardized interdisciplinary algorithm for the treatment of prosthetic joint infections. Bone Jt J. 2019; 101-B (2): 132–139.
  238. Preininger B. и др. Inadequacy of joint aspiration for detection of persistent periprosthetic infection during two-stage septic revision knee surgery. Orthopedics. 2017; 40 (4): 231–234.
  239. Wechter J. и др. Improved survival of uncemented versus cemented femoral stems in patients aged < 70 years in a community total joint registry. Clin. Orthop. Relat. Res. 2013; 471 (11): 3588–3595.
  240. Edwards P.K. и др. Are cementless stems more durable than cemented stems in two-stage revisions of infected total knee arthroplasties? Infection. Clin. Orthop. Relat. Res. 2014; 472 (1): 206–211.
  241. Gathen M. и др. Comparison of two-stage revision arthroplasty and intramedullary arthrodesis in patients with failed infected knee arthroplasty. Arch. Orthop. Trauma Surg. 2018; 138 (10): 1443–1452.
  242. Cochran A.R. и др. Risk of reinfection after treatment of infected total knee arthroplasty. J. Arthroplasty. 2016; 31 (9): 156–161.
  243. Fehring K.A. и др. Repeat two-stage exchange arthroplasty for periprosthetic knee infection is dependent on host grade. J. Bone Jt Surg. (A). 2017; 99 (1): 19–24.
  244. Byren I. и др. Randomized controlled trial of the safety and efficacy of daptomycin versus standard-of-care therapy for management of patients with osteomyelitis associated with prosthetic devices undergoing two-stage revision arthroplasty. Antimicrob. Agents Chemother. 2012; 56 (11): 5626–5632.
  245. Божкова С.А. и др. Резекционная артропластика с пересадкой островкового мы-шечного лоскута у больных с перипротезной инфекцией. Хирургия. Журн. Им. Н.И. Пирогова. 2020; (2): 32–38.
  246. Choa R. и др. Successful management of recalcitrant infection related to total hip replacement using pedicled rectus femoris or vastus lateralis muscle flaps. J. Bone Jt. Surg. (B). 2011; 93 B (6): 751–754.
  247. Куляба Т.А., Корнилов Н.Н. Ревизионная артропластика коленного сустава. СПб.: РНИИТО им. Р.Р.Вредена, 2016. 168 с.
  248. Balato G. и др. Re-infection rates and clinical outcomes following arthrodesis with intramedullary nail and external fixator for infected knee prosthesis: A systematic review and meta-analysis. BMC Musculoskelet. Disord. 2018; 19 (1).
  249. Соломин Л.Н. и др. Сравнительный анализ артродезирования коленного сустава длинными блокируемыми стержнями и аппаратом илизарова при последствиях глубокой инфекции после эндопротезирования. Травматол. Ортопед. России. 2020; 26 (3): 109-118.
  250. Gathen M. и др. Comparison of two-stage revision arthroplasty and intramedullary arthrodesis in patients with failed infected knee arthroplasty. Arch. Orthop. Trauma Surg. 2018; 138 (10): 1443–1452.
  251. Azzam K. и др. Outcome of a second two-stage reimplantation for periprosthetic knee infection. Clin. Orthop. Relat. Res. 2009; 467 (7): 1706–1714.
  252. Hawi N. и др. Septic single-stage knee arthrodesis after failed total knee arthroplasty using a cemented coupled nail. Bone Jt. J. (B) 2015; 97-B (5): 649–653.
  253. Hungerer S. и др. Knee arthrodesis versus above-the-knee amputation after septic failure of revision total knee arthroplasty: Comparison of functional outcome and complication rates. BMC Musculoskelet. Disord. 2017; 18 (1).
  254. Wu C.H., Gray C.F., Lee G.C. Arthrodesis should be strongly considered after failed two-stage reimplantation TKA. Clin. Orthop. Relat. Res. 2014; 472 (11): 3295–3304.
  255. Chen A.F. и др. Better function for fusions versus above-the-knee amputations for recurrent periprosthetic knee infection infection. Clin. Orthop. Rel. Res. 2012; 470 (10): 2737–2745.
  256. Rodriguez-Merchan E.C. Knee Fusion or above-the-knee amputation after failed two-stage reimplantation total knee arthroplasty. Arch. Bone Jt. Surg. 2015; 3 (4): 241.
  257. Backe H.A., Wolff D.A., Windsor R.E. Total knee replacement infection after 2-stage reimplantation: Results of subsequent 2-stage. Clin. Orthop. Relat. Res. 1996; 331: 125–131.
  258. Moura D.L., Garruço A. Hip disarticulation - case series analysis and literature review. Rev. Bras. Ortop. 2017; 52 (2): 154–158.
  259. Ghazavi M. Hip and knee section, treatment, salvage: proceedings of international consensus on orthopedic infections. J. Arthroplasty. 2019; 34 (2S): S459-S462.
  260. Kuo F.C. и др. Positive blood cultures decrease the treatment success in acute hematogenous periprosthetic joint infection treated with debridement, antibiotics, and implant retention. J. Arthroplasty. 2019; 34 (12): 3030-3034.
  261. Klement M.R. и др. Positive blood cultures in periprosthetic joint infection decrease rate of treatment success. J. Arthroplasty. 2018; 33 (1): 200-204.
  262. Bohl D.D. at al. Incidence, risk factors, and sources of sepsis following total joint arthroplasty. J. Arthroplasty. 2016; 31 (12): 2875-2879.
  263. Patel K.M. и др. Sepsis and total joint arthroplasty. Orthop. Clin. North Am. 2022; 53 (1): 13–24.
  264. Lenguerrand E. и др. Risk factors associated with revision for prosthetic joint infection following knee replacement: an observational cohort study from England and Wales. Lancet Infect. Dis. 2019; 19 (6).
  265. Lensen K.J. и др. Chronic prosthetic joint infections with a draining sinus. Who should receive suppressive antibiotic treatment? J. Bone Jt. Infect. 2020; 6 (2): 43–45.
  266. Lensen K.J.D.F. и др. The efficacy of suppressive antibiotic treatment in patients managed non-operatively for periprosthetic joint infection and a draining sinus. J. Bone Jt. Infect. 2021; 6 (7): 313–319.
  267. Ferry T. и др. The CRIOAc healthcare network in France: A nationwide Health Ministry program to improve the management of bone and joint infection. Orthop. Traumatol. Surg. Res. 2019; 105 (1): 185–190.
  268. Laurent E. и др. Multidisciplinary team meeting for complex bone and joint infections diagnosis: The PHICTOS study. Rev. Epidemiol. 2019; 67 (3): 149–154.
  269. Fang C. и др. Infection after fracture osteosynthesis - Part II: Treatment. J. Orthop. Surg. 2017; 25 (1): 1–11.
  270. Mote G.A., Malay D.S. Efficacy of power-pulsed lavage in lower extremity wound infections: a prospective observational study. J. Foot Ankle Surg. 2010; 49 (2): 135–142.
  271. Bezstarosti H. и др. Insights into treatment and outcome of fracture-related infection: a systematic literature review. Arch. Orthop. Trauma Surg. 2019; 139 (1): 61–72.
  272. Hake M.E. и др. Local antibiotic therapy strategies in orthopaedic trauma: Practical tips and tricks and review of the literature. Injury. 2015; 46 (8): 1447–1456.
  273. Zhang Y. и др. Double-level bone transport for large post-traumatic tibial bone defects: a single centre experience of sixteen cases. Int. Orthop. 2018; 42 (5): 1157–1164.
  274. Metsemakers W.J. et al. Fracture-Related Infection (FRI) group. General treatment principles for fracture-related infection: recommendations from an international expert group. Arch. Orthop. Trauma Surg. 2020; 140 (8): 1013-1027.
  275. Aytaç S. et al. Posttraumatic and postoperative osteomyelitis: surgical revision strategy with persisting fistula. Arch. Orthop. Trauma Surg. 2014; 134 (2): 159–165.
  276. Щепкина Е.А. и др. Сравнительная оценка замещения посттравматических дефектов бедренной и большеберцовой костей по илизарову и поверх интрамедуллярного стержня. Медико-биолог. и социально-психолог. проблемы безопасности в чрезвычайных ситуациях. 2021; (2): 80-88.
  277. Kadhim M. и др. Treatment options for nonunion with segmental bone defects: systematic review and quantitative evidence synthesis. J. Orthop. Trauma. 2017; 31 (2): 111–119.
  278. McNally M. et al. What factors affect outcome in the treatment of fracture-related infection? Antibiotics (Basel). 2022; 11 (7): 946.
  279. Morgenstern M. et al. The effect of local antibiotic prophylaxis when treating open limb fractures: a systematic review and meta-analysis. Bone Jt Res. 2018; 7(7): 447–456..
  280. McKee M.D. и др. A prospective, randomized clinical trial comparing an antibiotic-impregnated bioabsorbable bone substitute with standard antibiotic-impregnated cement beads in the treatment of chronic osteomyelitis and infected nonunion. J. Orthop. Trauma. 2010; 24 (8): 483–490.
  281. Kocaoglu M. и др. Reconstruction of segmental bone defects due to chronic osteomyelitis with use of an external fixator and an intramedullary nail. J. Bone Jt. Surg. (A). 2006; 88 (10): 2137–2145.
  282. Li Z. и др. Distraction osteogenesis technique using an intramedullary nail and a monolateral external fixator in the reconstruction of massive postosteomyelitis skeletal defects of the femur. Can. J. Surg. 2009; 52 (2).
  283. Depypere M. et al. Fracture-related Infection (FRI) Consensus Group. Recommendations for systemic antimicrobial therapy in fracture-related infection: a consensus from an International Expert Group. J. Orthop. Trauma. 2020; 4 (1): 30-41.
  284. Berkes M. и др. Maintenance of hardware after early postoperative infection following fracture internal fixation. J. Bone Jt. Surg. (A). 2010; 92 (4): 823–828.
  285. Metsemakers W.J. и др. Evidence-based recommendations for local antimicrobial strategies and dead space management in fracture-related infection. J. Orthop. Trauma. 2020; 34 (1): 18–29.
  286. Cierny G. Surgical treatment of osteomyelitis. Plast. Reconstr. Surg. 2011; 127 (Suppl. 1).
  287. Клюшин Н.М. и др. Клинические рекомендации «Остеомиелит» [Электронный ресурс]. 2016. Т. 2016. С. 68. URL: http://kokb45.ru/wp-content/uploads/2018/06 /Osteomielit.pdf.
  288. Siddiqi A. и др. Perioperative antibiotic prophylaxis in total joint arthroplasty: A systematic review and meta-analysis. J. Bone Jt. Surg. (A). 2019; 101 (9): 828–842.
  289. Backes M. и др. Wound infections following implant removal below the knee: The effect of antibiotic prophylaxis; The WIFI-trial, a multi-centre randomized controlled trial. BMC Surg. 2015; 15 (1).
  290. Sanders F.R.K. и др. Comparison of 2g vs 1 g of prophylactic cefazolin in surgical site infections in trauma surgery below the knee. Foot Ankle Int. 2020; 41 (5): 582–589.
  291. Wong M.T. Can topical vancomycin prevent periprosthetic joint infection in hip and knee arthroplasty? a systematic review. Clin Orthop Relat Res. 2021; 479 (8): 1655-1664.
  292. Kim P.H., Leopold S.S. Gustilo-Anderson classification. Clin. Orthop. Relat. Res. 2012; 470 (11): 3270–3274.
  293. Sorger J.I. и др. Once daily, high dose versus divided, low dose gentamicin for open fractures. Clin. Orthop. Relat. Res. 1999; 366: 197–204.
  294. Hoff W.S. и др. East practice management guidelines work group: Update to practice management guidelines for prophylactic antibiotic use in open fractures. J. Trauma - Inj. Infect. Crit. Care. 2011; 70 (3): 751–754.
  295. Murray C.K. и др. Prevention of infections associated with combat-related extremity injuries. J. Trauma Inj. Infect. Crit. Care. 2011; 71 (2).
  296. Takahara S. и др. Ampicillin/sulbactam versus cefazolin plus aminoglycosides for antimicrobial prophylaxis in management of Gustilo type IIIA open fractures: A retrospective cohort study. Injury. 2022; 53 (4): 1517–1522.
  297. Trauma – ICM Philly [Электронный ресурс]. URL: https://icmphilly.com/trauma/ (дата обращения: 25.05.2020).
  298. Парвизи Д., Торстен Г. Материалы международной согласительной конференции по перипротезной инфекции /Под ред. Р.М. Тихилова. СПб.: РНИИТО, 2014. 355 с.
  299. Elia M. и др. A systematic review of the cost and cost effectiveness of using standard oral nutritional supplements in the hospital setting. Clin. Nutr. 2016; 35 (2): 370–380.
  300. Metsemakers W.J. и др. General treatment principles for fracture-related infection: recommendations from an international expert group. Arch. Orthop. Trauma Surg. 2020; 140 (8): 1013–1027.
  301. Pani A. et al. Off-label use of ceftaroline fosamil: A systematic review. Int. J. Antimicrob. Agents. 2019; 54 (5): 562-571.
  302. Barber K.E. и др. Evaluation of ceftaroline alone and in combination against biofilm-producing methicillin-resistant Staphylococcus aureus with reduced susceptibility to daptomycin and vancomycin in an in vitro pharmacokinetic/pharmacodynamic model. Antimicrob. Agents Chemother. 2015; 59 (8): 4497–4503.
  303. Garrigues G.E. и др. Proceedings from the 2018 International Consensus Meeting on Orthopedic Infections: evaluation of periprosthetic shoulder infection. J. Shoulder Elb. Surg. 2019; 28 (6).
  304. Tang H. и др. In vitro efficacy of fosfomycin-containing regimens against methicillin-resistant Staphylococcus aureus in biofilms. J. Antimicrob. Chemother. 2012; 67 (4): 944–950.
  305. Soriano A. и др. Efficacy and tolerability of prolonged linezolid therapy in the treatment of orthopedic implant infections. Eur. J. Clin. Microbiol. Infect. Dis. 2007; 26 (5): 353–356.
  306. Rao N., Hamilton C.W. Efficacy and safety of linezolid for Gram-positive orthopedic infections: a prospective case series. Diagn. Microbiol. Infect. Dis. 2007; 59 (2): 173–179.
  307. Benavent E. et al. Long-term use of tedizolid in osteoarticular infections: benefits among oxazolidinone drugs. Antibiotics. 2021; 10 (1): 53
  308. Park K.H. et al. Activity of Tedizolid in methicillin-resistant Staphylococcus aureus experimen-tal foreign body-associated osteomyelitis. Antimicrob. Agents Chemother. 2016; 60: 6568–6572.
  309. Assis L.M., Nedeljković M., Dessen A. New strategies for targeting and treatment of multi-drug resistant Staphylococcus aureus. Drug Resist. Updat. 2017; 31 (2017): 1–14.
  310. Holmberg A., Rasmussen M. Antibiotic regimens with rifampicin for treatment of Enterococcus faecium in biofilms. Int. J. Antimicrob. Agents. 2014; 44 (1): 78–80.
  311. Lomas J. Antimicrobial treatment in bone and joint infections. Orthop. Trauma. 2019; 33 (3): 153–159.
  312. Lastinger A. et al. Clinical experience with tigecycline in the treatment of prosthetic joint infections. J. Bone Jt Infect. 2019; 4 (3): 126-132.
  313. Tsuji B.T. et al. International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti-infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP). Pharmacotherapy. 2019; 39 (1): 10-39.
  314. de Sanctis J. et al. Complex prosthetic joint infections due to carbapenemase-producing Klebsiella pneumoniae: a unique challenge in the era of untreatable infections. Int. J. Infect. Dis. 2014; 25: 73-78.
  315. Конев В.А. и др. Результаты применения фосфомицина для импрегнации остеозамещающих материалов при лечении хронического остеомиелита. Травматол. Ортопед. России 2016; 22 (2): 43–56.
  316. Божкова С.А. и др. Фосфомицин — возможности применения для локальной терапии перипротезной инфекции. Клин. Микробиол. Антимикроб. химиотерапия. 2016; 18 (2): 104–112.
  317. Божкова С.А. и др. Клинико-экономическая эффективность использования фосфомицина и ванкомицина для импрегнации спейсеров при хирургическом лечении пациентов с перипротезной инфекцией. Травматол. Ортопед. России. 2017; 23 (2): 122–131.
  318. Артюх В.А. и др. Способ изготовления цементного спейсера для этиотропной местной антибактериальной терапии при инфекционных поражениях костей и суставов. Патент на изобретение RU 2754075 C1. 25.08.2021. Бюл. № 24 Заявка № 2020139552 от 01.12.2020.
  319. Bernard L. и др. Antibiotic therapy for 6 or 12 weeks for prosthetic joint infection. N. Engl. J. Med. 2021; 384 (21): 1991-2001.
  320. Pradier M.et al. Suppressive antibiotic therapy with oral doxycycline for Staphylococcus aureus prosthetic joint infection: a retrospective study of 39 patients. Int. J. Antimicrob. Agents. 2017; 50 (3): 447–452.
  321. Rempenault C. et al. Treatment of bone and joint infections by ceftazidime/avibactam and ceftolozane/tazobactam: a cohort study. J. Glob. Antimicrob. Resist. 2021; 25: 282-286.
  322. Schimmenti A. Prosthetic joint infection from carbapenemase-resistant Klebsiella pneumoniae successfully treated with ceftazidime-avibactam. Case Rep Infect Dis. 2018; 1854805.
  323. Toor R., Garcia E. 607: Ceftazidime-avibactam and aztreonam against multidrug- resistant Pseudomonas aeruginosa. Crit. Care Med. 2020; 48 (1): 284
  324. Mularoni A. et al. Combination of aztreonam, ceftazidime-avibactam and amikacin in the treatment of VIM-1 Pseudomonas aeruginosa ST235 osteomyelitis. Int. J. Infect. Dis. 2021; 108: 510-512.
  325. Oliveira P. R. et al. Tigecycline versus colistin in the treatment of carbapenem-resistant Acinetobacter baumannii complex osteomyelitis. J. Bone Jt Infect. 2020; 5: 60–66.
  326. Tabaja H, Tai DBG, Beam E, Abdel MP, Tande AJ. Clinical Profile of Monomicrobial Corynebacterium Hip and Knee Periprosthetic Joint Infections. Open Forum Infect Dis. 2022 Apr 14;9(7):ofac193. doi: 10.1093/ofid/ofac193.

Для продолжения работы требуется Регистрация
На предыдущую страницу

Предыдущая страница

Следующая страница

На следующую страницу
Список литературы
На предыдущую главу Предыдущая глава
оглавление
Следующая глава На следующую главу

Оглавление

Данный блок поддерживает скрол*